|
SRI
|
OGG_3000006717 |
|
|
captopril
|
CHEBI_3380 |
[A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.] |
|
membrane attack complex
|
GO_0005579 |
[A protein complex produced by sequentially activated components of the complement cascade inserted into a target cell membrane and forming a pore leading to cell lysis via ion and water flow.] |
|
plasma membrane protein complex
|
GO_0098797 |
[Any protein complex that is part of the plasma membrane.] |
|
carbamazepine
|
CHEBI_3387 |
[A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.] |
|
central nervous system drug
|
CHEBI_35470 |
[A class of drugs producing both physiological and psychological effects through a variety of mechanisms involving the central nervous system.] |
|
CDKN1A
|
OGG_3000001026 |
|
|
Chylomicrons
|
OMIT_0004233 |
|
|
ND1
|
OGG_3000004535 |
|
|
CDKN2A
|
OGG_3000001029 |
|
|
SRC
|
OGG_3000006714 |
|
|
GAPDHS
|
OGG_3000026330 |
|
|
CDO1
|
OGG_3000001036 |
|
|
Hexokinase
|
OMIT_0007752 |
|
|
lead atom
|
CHEBI_25016 |
|
|
inclusion body
|
GO_0016234 |
[A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers.] |
|
Lavandula
|
NCBITaxon_39169 |
|
|
RAC1
|
OGG_3000005879 |
|
|
Study Arm
|
NCIT_C174447 |
[A planned pathway assigned to the subject as they progress through the study, usually referred to by a name that reflects one or more treatments, exposures, and/or controls included in the path.] |
|
active transport
|
REX_0000120 |
[The carriage of a solute across a biological membrane from low to high concentration which requires the expenditure of (metabolic) energy.] |
